Discussions

The 44th JP Morgan Healthcare conference has highlighted the main theme of future of life sciences, one of which is shifting of oral medicines for obesity. This is one of the major game changes in the anti-obesity market, which will shift from weekly injectables to daily oral medicines. Novo Nordisk quoted that at the end of the decade one in three obesity patients could be using oral medicines for weight loss. The continuous innovation and research happening in the promising market of anti-obesity is attracting lot of investments and companies are signing multiple collaborations. To know more about the recent trend and future opportunities, please visit https://www.rootsanalysis.com/reports/anti-obesity-drugs-market.html

The newly published market report titled Anti-Obesity Drugs Market analysis offers a robust, data-centric perspective on how the Anti-Obesity Drugs industry has evolved and where it is headed through 2035. Built on credible, verified insights, the study delivers a structured review of market size, geographic expansion, and strategic behavior across stakeholders.

I recently came across a report by Roots Analysis that really put things into perspective. According to them, the anti-obesity drugs market, valued at USD 12.8 billion in 2024, is projected to grow to USD 19.6 billion in 2025 and USD 104.9 billion by 2035, representing a CAGR of 18.3% during the forecast period.

The research highlights general factors that may be contributing to market expansion, offering a neutral and data-focused view. The Anti-Obesity Drugs Market forecast is based on the analysis of available information, without assigning speculative cause-and-effect reasoning to specific trends.

Report Highlights

Key Questions Answered

• Question 1: What are anti-obesity drugs?

• Question 2: How big is the market for weight loss drugs?

• Question 3: What is the growth rate (CAGR) of the anti-obesity drugs market?

• Question 4: What is the future of anti-obesity medications?

• Question 5: Which region has the highest share of the anti-obesity drugs market?

• Question 6: What is the leading type of molecule in anti-obesity drugs?

• Question 7: What are the key factors driving the demand for anti-obesity drugs?

• Question 8: What companies are making weight loss drugs?

• Key Report Attributes

• Historical Trends

• Forecast Period

• Market Size, 2025

• Market Size, 2035

• CAGR

• Type of Molecule

• Active Compound Used

• Mechanism of Action

• Type of Agonist

• Action Pathway

• Route of Administration

• Geographical Regions

• Sales Forecast

• Key Players

• Key Companies Profiled in theAnti-Obesity Drugs Market

• Customization Scope

• Excel Data Packs(Complimentary)

Regional Analysis:
• North America, Europe, Asia-Pacific, Latin America
Company Review: Top players include, Eli Lilly, Novo Nordisk, Pfizer and other Drug Developers. Each profile examines regional strategy, clinical trial activity, promotional activities and product focus.
Anti-Obesity Drugs Market Report Coverage
▪ A preface providing an introduction to the full report, Anti-obesity Drugs Market, till 2035 .

The research also explores how suppliers, distributors, and end-users engage within the current Anti-Obesity Drugs Market ecosystem, highlighting the operational interplay driving this market forward.

Research Integrity

Report is prepared using a blend of primary interviews, public datasets, and proprietary databases.
Collection of relevant data points to facilitate the process of market estimation.
Integrating micro and macro parameters, which influence the pace of market progression
Analyzing growth opportunities across various market segments
Need a tailored summary or extended breakdown of the data? Reach out to our team for custom insights specific to your business focus.

About Roots Analysis

Roots Analysis is a global research and consulting powerhouse specializing in Healthcare, Pharmaceutical, Biotech, Semiconductors, Chemicals and ICT industry. With over a decade of experience, they’ve supported more than 750 clients — spanning Fortune 500 companies, innovative startups, academic institutions, VCs, and strategic investors.

Why Use Roots Analysis in era of Artificial Intelligence?

Tailored Insights
Robust Methodology
Smart Decisions Made Easy
By combining world-class domain expertise, careful data gathering, and dialogue with senior industry experts, Roots Analysis ensures their deliveries are trustworthy, actionable, and aligned with strategic priorities. The value proposition generated on insights generated by Roots Analysis team is unparalleled in the market research industry.

Services Offered:

Consulting Services (custom insights supporting strategic and tactical requirements, off-the-shelf ready to consume work)
Roots Analysis offers bespoke consulting services tailored to the unique needs of clients in the life sciences and healthcare sectors.

They specialize in market assessments, tracking industry trends, dynamics, and competitive positioning. These insights help companies fine-tune their product strategies and market-entry plans.

Roots Analysis also delivers expert guidance on partnerships, licensing, and investment opportunities. Their strategic support extends to KOL identification, publication analysis, and regulatory intelligence, making them a valuable partner in business growth and innovation.

Subscription Services (bundled services supporting multiple topics and domains for a firm)
With their subscription plans, Roots Analysis provides seamless access to a vast library of market intelligence reports. Subscribers enjoy unlimited downloads in multiple formats.

The service includes on-demand research support—allowing clients to request tailored insights and initiate custom research topics. This ensures that emerging needs are met quickly and effectively.

Each subscription comes with a dedicated account manager and direct access to analysts. Flexible billing options and tiered plans make this service suitable for organizations of all sizes seeking continuous, reliable insights.

Contact Details for Roots Analysis

Chief Executive: Gaurav Chaudhary

Email: [email protected]

Website: https://www.rootsanalysis.com/